Jiangsu gdk Biotechnology Co Ltd
688670
Company Profile
Business description
Jiangsu gdk Biotechnology Co Ltd is engaged in the Research, development, production, and sales of human vaccines. It is a high-tech biotechnology enterprise integrating human vaccine research, production, sales, and services, possessing comprehensive technological development capabilities, developed technology, developed production and testing equipment, and a scientific and standardized management and quality assurance system.
Contact
No. 12 Yujin Road
Jiangsu Province
Taizhou225300
CHNT: +86 52386205860
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
390
Stocks News & Analysis
stocks
Australia’s oldest REIT undervalued
This REIT remains undervalued as trophy properties shine through.
stocks
Stop asking if there’s a stock market bubble. Ask this instead.
Why earnings growth might be more important when assessing frothy market conditions.
stocks
Are negative AI narratives holding this ASX share back?
This company is unlikely to be disrupted by AI
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,935.90 | 67.10 | -0.75% |
| CAC 40 | 8,403.99 | 36.66 | 0.44% |
| DAX 40 | 24,995.81 | 368.92 | 1.50% |
| Dow JONES (US) | 52,319.20 | 136.46 | 0.26% |
| FTSE 100 | 10,497.12 | 12.90 | 0.12% |
| HKSE | 22,881.02 | 145.66 | -0.63% |
| NASDAQ | 26,213.72 | 393.58 | 1.52% |
| Nikkei 225 | 70,672.90 | 610.58 | 0.87% |
| NZX 50 Index | 13,610.50 | 11.16 | -0.08% |
| S&P 500 | 7,499.36 | 58.93 | 0.79% |
| S&P/ASX 200 | 8,726.30 | 68.30 | -0.78% |
| SSE Composite Index | 4,094.40 | 20.50 | 0.50% |